Gapping up
In reaction to strong earnings/guidance: N/A
M&A news:
In reaction to strong earnings/guidance: N/A
M&A news:
- CYNO +8.3% (Bloomberg reported co is exploring strategic alternatives)
- KATE +4.7% (speculation on Friday of possible bidders)
- BNCN +4.1% (to be acquired by Pinnacle Financial Partners (PNFP))
Select metals/mining stocks trading higher:
- SBGL +5.1%, AU +3.9%, VALE +3.4%, GOLD +1.9%, AG +1.9%, AUY +1.9%, RIO +1.6%, PAAS +1.4%, NEM +1.3%
- ABX +1.2%, GDX +1.1%, GFI +0.9%, BHP +0.9%, BBL +0.8%, HMY +0.8%
Other news:
- MRNS +31.9% (announces 'positive' prelim data from the initial CDKL5 patients enrolled in its ongoing Phase 2study evaluating ganaxolone as a treatment for orphan, genetic disorders)
- BIOL +13.6% (confirms 510(k) clearance for commercial distribution in the US of its Epic Pro laser system from the FDA)
- ETRM +7.9% (continued momentum higher)
- NQ +4% (enters into non-binding letter of intent for the sale of FL Mobile, announces proposed $100 mln investment at $5.25/share)
- BMY +0.9% (announces settlement and license agreement with Bristol-Myers (BMY) resolving Keytruda patent litigation; co to make a one-time payment to BMY of $625 mln)
Analyst comments:
- CSX +0.9% (upgraded to Outperform from Market Perform at BMO Capital)